NCT07145125 2025-11-21
HL-R2-B2
University Hospital, Bordeaux
Completed
Clinical Trials
5 trialsNCT02491398 2020-10-06
LLC1315
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT02381899 2019-02-01
Observational Study in CLL Patients Receiving BR
Czech CLL Study Group
Completed
NCT02110394 2016-07-06
NORMA
Astellas Pharma Inc
Completed
NCT02072967 2016-02-22
Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Astellas Pharma Inc
Completed